据悉,酝酿了3年之久的新版《药品生产质量管理规范》(简称新版GMP)已经完成,由于新版GMP提高了药企的准入门槛,部分中小型企业将迎来巨大挑战。对此,国家食品药品监督管理局的相 It is reported that the new version of the “Pharmaceutical Production Quality Management Standard” (abbreviated as the new version of GMP) that has been brewing for three years has been completed. As the new version of GMP has increased the access threshold for pharmaceutical companies, some small and medium-sized enterprises will face enormous challenges. In this regard, the State Food and Drug Administration